Hering-Breuer reflex after bilateral lung transplant
The Hering-Breuer Reflex in Bilateral Lung Transplant Patients
This study will test whether the Hering-Breuer inflation reflex is preserved in adults recovering from bilateral lung transplant and whether changing PEEP (8 vs 12 cmH₂O) alters the reflex compared with intubated patients after non-thoracic surgery.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 22 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Policlinico Hospital Academic / other |
| Locations | 1 site (Milan, Michigan) |
| Trial ID | NCT07280611 on ClinicalTrials.gov |
What this trial studies
This single-center, non-pharmacologic interventional study will enroll intubated adults in the ICU during early weaning after bilateral lung transplantation and a comparison group of intubated patients after major non-thoracic surgery. Investigators will elicit the Hering-Breuer inflation reflex via nasogastric tube maneuvers and quantify it using the ratio THBR/TSPONT. Reflex measurements will be made at two levels of positive end-expiratory pressure (PEEP 8 vs 12 cmH₂O) to see how end-expiratory pressure modulates the response. The transplant and control arms will be compared to determine whether the reflex is absent, attenuated, or differently modulated by PEEP in double-lung-transplant recipients.
Who should consider this trial
Good fit: Adults (age ≥18) who are intubated and in the early weaning phase in the ICU after bilateral lung transplantation, with a control group of intubated ICU patients after non-thoracic surgery.
Not a fit: Patients with single-lung or re-transplantation, urgent transplants, marked low respiratory compliance, hemodynamic instability, or high bleeding risk from nasogastric tube placement are excluded and unlikely to benefit from participation.
Why it matters
Potential benefit: If successful, results could improve understanding of respiratory control after lung transplant and help inform ventilator weaning strategies.
How similar studies have performed: Physiologic studies have described the Hering-Breuer reflex in healthy subjects and some ICU contexts, but its status after bilateral lung transplantation and response to PEEP remains largely untested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age \>18 years; * Both sexes; * For group 1: patients admitted to the Intensive Care Unit after undergoing bilateral lung transplantation, during respiratory weaning; * For group 2: patients admitted to the Intensive Care Unit for support or monitoring after non-thoracic surgery, who will arrive intubated. Exclusion Criteria: For group 1, patients meeting at least one of the following criteria will be excluded: * Re-transplantation or single-lung transplantation; * Urgent lung transplantation; * Post-transplant respiratory system compliance \< 30 mL/cmH₂O; * Hemodynamic instability (defined as the presence of one or more of the following: plasma lactate \> 4 mmol/L, need for vasoactive support with norepinephrine and/or epinephrine at a dose \> 0.05 mcg/kg/min, systolic arterial pressure \< 80 mmHg); * Increased risk of bleeding related to the placement of a nasogastric tube due to coagulopathy or severe thrombocytopenia (INR \> 2 and platelets \< 70,000); * Pregnancy For group 2, patients presenting with one or more of the following criteria will be excluded: * Postoperative respiratory system compliance \< 30 mL/cmH₂O; * Hemodynamic instability (defined as the presence of one or more of the following: plasma lactate \> 4 mmol/L, need for vasoactive support with norepinephrine and/or epinephrine at a dose \> 0.05 mcg/kg/min, systolic arterial pressure \< 80 mmHg); * Contraindications to nasogastric tube placement (gastroesophageal surgery within the last 3 months, gastroesophageal bleeding in the previous 30 days, esophageal varices, facial trauma); * Increased risk of bleeding related to the placement of a nasogastric tube due to coagulopathy or severe thrombocytopenia (INR \> 2 and platelets \< 70,000); * History of lung transplantation or major thoracic surgery; * Pregnancy.
Where this trial is running
Milan, Michigan
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico — Milan, Michigan, Italy (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.